Menu

Reconciliation of alternative performance measures


In CHF million
 
1.1.–30.6.2021
 
1.1.–30.6.2020
 
Change reported
  Change at constant
exchange rates
                 
Net revenue                
Net revenue   5,583   5,443   2.6%   2.0%
                 
Operating income before depreciation and amortisation (EBITDA)                
EBITDA   2,317   2,208   4.9%   4.4%
Gain from change in pension plan   (60)          
Additions to provisions for legal proceedings in Switzerland   22          
EBITDA adjusted   2,279   2,208   3.2%   2.7%
                 
Capital expenditure                
Capital expenditure in property, plant and equipment and intangible assets   1,078   1,069   0.8%   0.1%
Payments for indefeasible rights of use (IRU)   5   6   –16.7%    
Capital expenditure   1,083   1,075   0.7%   –%
In CHF million   1.1.–30.6.2021   1.1.–30.6.2020   Change reported
             
Operating free cash flow proxy            
Cash flow from operating activities   1,831   1,950   (119)
Capital expenditure   (1,083)   (1,075)   (8)
Depreciation of right-of-use assets   (141)   (147)   6
Depreciation of indefeasible rights of use (IRU)   12   12  
Impairment losses of right-of-use assets     7   (7)
Change in deferred gain from the sale and leaseback of real estate   8   6   2
Change in operating assets and liabilities   121   71   50
Change in provisions   2   10   (8)
Change in net defined benefit liabilities   36   (29)   65
Gain on sale of property, plant and equipment   3     3
Expense for share-based payments   (1)   (1)  
Revenue from finance leases   51   27   24
Interest received   (2)   (9)   7
Interest payments on financial liabilities   18   20   (2)
Dividends received   (1)   (15)   14
Income taxes paid   229   156   73
Operating free cash flow proxy   1,083   983   100
     
             
Free cash flow            
Cash flow from operating activities   1,831   1,950   (119)
Cash flow used in investing activities   (836)   (1,066)   230
Repayment of lease liabilities   (152)   (151)   (1)
Acquisition of subsidiaries, net of cash and cash equivalents acquired   25   16   9
Proceeds from equity-accounted investees   (134)     (134)
Expenses for shareholdings accounted for using the equity method   1   9   (8)
Purchase of other financial assets   11   18   (7)
Proceeds from other financial assets   (101)   (12)   (89)
Other cash flows from investing and financing activities   1   (3)   4
Free cash flow   646   761   (115)